Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

TBI-166

TBI-166 is an orally bioavailable riminophenazine compound developed as a next-generation anti-tuberculosis agent. It demonstrates potent activity against Mycobacterium tuberculosis in both in vitro and in vivo models while exhibiting an improved safety profile compared to Clofazimine.

Product Specifications

CAS Number

1353734-12-9

Field of Research

Infectious Disease & Virology

Smiles

N (=C1C=C2N (C=3C (N=C2C=C1NC4=C (OC) N=CC=C4) =CC=CC3) C5=CC=C (OC (F) (F) F) C=C5) C6CCC (OC) CC6

Molecular Formula

C32H30F3N5O3

Molecular Weight

589.61

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

SYPL2 siRNA (Mouse)
CRM2531-01 15 nmol

SYPL2 siRNA (Mouse)

Sign In for Pricing
View Details
SYPL2 siRNA (Mouse)
CRM2531-02 30 nmol

SYPL2 siRNA (Mouse)

Sign In for Pricing
View Details
hsa-miR-4436b-5p Primers
MPH02659 150 µL / 10 µM

hsa-miR-4436b-5p Primers

Sign In for Pricing
View Details
Lentiviral human CST6 sgRNA gene knockout kit - Lentiviral human CST6 sgRNA gene knockout kit (plasmid)
GTR15395819 1 Vial

Lentiviral human CST6 sgRNA gene knockout kit - Lentiviral human CST6 sgRNA gene knockout kit (plasmid)

Sign In for Pricing
View Details
Human B-Cell Receptor CD22 (CD22) Protein
abx657366-01 50 µg

Human B-Cell Receptor CD22 (CD22) Protein

Sign In for Pricing
View Details
Human B-Cell Receptor CD22 (CD22) Protein
abx657366-02 100 µg

Human B-Cell Receptor CD22 (CD22) Protein

Sign In for Pricing
View Details